Search results for "ATEROSCLEROSI"
showing 10 items of 72 documents
Should we routinely measure low-density and high-density lipoprotein subclasses?
2009
Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) plasma populations are composed of heterogeneous subfractions that are different in size, density and protein/lipid content. There is increasing evidence that small, dense LDL particles are strongly associated with higher cardiovascular disease risk. Similarly, several studies have investigated whether smaller HDL particles are more protective than their larger counterparts and more recent findings suggest that small, dense HDL has significantly higher atheroprotective activity than larger L HDL. Yet, certain impairments of the protein/lipid content in small, dense HDL may decrease its antiatherogenic capacity or even induce p…
Elevated levels of non-HDL-cholesterol are relatively uncommon in women with PCOS and generally reflect LDL-cholesterol levels.
2009
Low circulating levels of HDL-cholesterol in women with PCOS and no other lipid abnormalities are associated to increased carotid intima media thickn…
2009
Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients.
2008
Background. Hypertension and additional non-traditional risk factors can damage the kidney directly and by promoting atherogenesis. Evidence indicates that increased oxidative stress and inflammation may mediate a large part of the effects of risk factors on the kidney. We hypothesized that in hypertensive patients (HT), oxidative stress, measured as 8-ISO-prostaglandin F2alpha (8-ISO-PGF2alpha), should raise paralleling decreasing renal function and should correlate with estimated glomerular filtration rate (eGFR). Methods. In 626 HT with renal function ranging from stages 1 to 5 and 100 healthy controls, plasma levels of 8-ISO-PGF2alpha, high-sensitivity C-reactive protein (CRP), transfor…
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
2009
Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia.
2010
L’eta’ e gli elevati livelli di proteina C-reattiva e fibrinogeno sono forti predittori di eventi clinici in una popolazione di donne con aterosclero…
2007
Study of the systemic inflammation associated to primary hypercholesterolemia, its modulation and its impact in atherosclerosis. Role of CXCL16/CXCR6…
2019
La hipercolesterolemia primaria (HP) es un desorden metabólico caracterizado por unos elevados niveles circulantes de lipoproteínas de baja densidad (LDL), así como por una inflamación sistémica de bajo grado, que puede finalmente dar lugar al desarrollo de aterosclerosis. Debido a la escasa información que se tiene de la enfermedad a nivel inmunológico, hemos caracterizado el comportamiento de diferentes mediadores solubles y celulares de la inflamación y sus posibles consecuencias. Para ello se ha empleado sangre completa de 22 pacientes con HP y 21 controles de semejante edad. En todos ellos se ha analizado la sangre por citometría de flujo para determinar la activación leucocitaria y pl…
Influencia de la variabilidad glucémica sobre la salud micro y macrovascular en niños y adolescentes con diabetes tipo 1
2015
INTRODUCCIÓN: La enfermedad cardiovascular precoz es la principal causa de morbi-mortalidad en el paciente diabético. Se ha demostrado que el estrés oxidativo, responsable del daño vascular, es mayor en condiciones de hiperglucemia intermitente que durante la hiperglucemia mantenida. La implicación de la variabilidad glucemia como causa de las complicaciones vasculares de la diabetes es controvertida y prácticamente no estudiada en la edad pediátrica. HIPÓTESIS: La variabilidad glucémica se relaciona en niños y adolescentes diabéticos tipo 1 con las complicaciones subclínicas macro y microvasculares. MATERIAL Y MÉTODOS: Estudio transversal, analítico y observacional realizado en la Unidad d…